Financial Analysis: QXO (NYSE:QXO) vs. BioNexus Gene Lab (NASDAQ:BGLC)

BioNexus Gene Lab (NASDAQ:BGLC) and QXO (NYSE:QXO) are both industrials companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Institutional & Insider Ownership

18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 58.7% of QXO shares are held by institutional investors. 0.1% of BioNexus Gene Lab shares are held by company insiders. Comparatively, 41.0% of QXO shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares BioNexus Gene Lab and QXO’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioNexus Gene Lab	-82.38%	-32.92%	-29.75%
QXO	-5.17%	2.41%	1.20%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for BioNexus Gene Lab and QXO, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNexus Gene Lab	1	0	0	0	1.00
QXO	1	1	14	2	2.94

QXO has a consensus target price of $25.36, indicating a potential upside of 134.46%. Given QXO’s stronger consensus rating and higher probable upside, analysts clearly believe QXO is more favorable than BioNexus Gene Lab.

Valuation & Earnings

This table compares BioNexus Gene Lab and QXO”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNexus Gene Lab	$7.43 million	0.51	-$2.98 million	($1.26)	-1.02
QXO	$6.84 billion	1.64	-$279.40 million	($0.90)	-12.02

BioNexus Gene Lab has higher earnings, but lower revenue than QXO. QXO is trading at a lower price-to-earnings ratio than BioNexus Gene Lab, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

BioNexus Gene Lab has a beta of 4.22, suggesting that its stock price is 322% more volatile than the S&P 500. Comparatively, QXO has a beta of 2.3, suggesting that its stock price is 130% more volatile than the S&P 500.

Summary

QXO beats BioNexus Gene Lab on 12 of the 15 factors compared between the two stocks.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

About QXO

QXO, Inc. operates as a business application, technology, and consulting company in North America. The company provides solutions for accounting and business management, financial reporting, enterprise resource planning, human capital management, warehouse management systems, customer relationship management, and business intelligence. It also offers value-added services that focuses on consulting and professional, specialized programming, training, and technical support services. In addition, the company provides information technology managed services, such as cybersecurity, application hosting, disaster recovery, business continuity, cloud, and other services; and data back-up, network maintenance, and upgrade services. It serves small and medium-sized businesses primarily in the manufacturing, distribution, and service industries. QXO, Inc. is headquartered in Greenwich, Connecticut.